Compounds > 1,4-dihydropyridine
Page last updated: 2024-08-26

1,4-dihydropyridine and Diabetes Mellitus, Type 2

1,4-dihydropyridine has been researched along with Diabetes Mellitus, Type 2 in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (60.00)29.6817
2010's2 (40.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Arima, H; Chalmers, J; Harrap, S; Hirakawa, Y; Mancia, G; Patel, A; Poulter, N; Williams, B; Woodward, M; Zoungas, S1
Bakris, GL; Yamout, H1
Logan, A1
Berenshteĭn, NV; Burmistrova, LF; Iskenderov, BG; Lokhina, TV1
Bakris, GL; Epstein, M; Goldberg, R; Hung, E; Preston, R; Richardson, DJ; Smith, AC1

Trials

4 trial(s) available for 1,4-dihydropyridine and Diabetes Mellitus, Type 2

ArticleYear
Effects of combination of perindopril, indapamide, and calcium channel blockers in patients with type 2 diabetes mellitus: results from the Action In Diabetes and Vascular Disease: Preterax and Diamicron Controlled Evaluation (ADVANCE) trial.
    Hypertension (Dallas, Tex. : 1979), 2014, Volume: 63, Issue:2

    Topics: Adult; Aged; Antihypertensive Agents; Blood Pressure; Calcium Channel Blockers; Diabetes Mellitus, Type 2; Dihydropyridines; Drug Combinations; Drug Therapy, Combination; Female; Gliclazide; Humans; Hypertension; Hypoglycemic Agents; Indapamide; Male; Middle Aged; Perindopril; Proportional Hazards Models

2014
BENEDICT in the treatment of hypertension.
    Current hypertension reports, 2005, Volume: 7, Issue:2

    Topics: Albuminuria; Angiotensin-Converting Enzyme Inhibitors; Blood Glucose; Blood Pressure; Calcium Channel Blockers; Creatinine; Diabetes Mellitus, Type 2; Dihydropyridines; Double-Blind Method; Drug Therapy, Combination; Follow-Up Studies; Glycated Hemoglobin; Humans; Hypertension; Indoles; Treatment Outcome; Verapamil

2005
[Hypotensive efficacy and tolerability of combination of dihydropyridine and non-dihydropyridine calcium antagonists in the treatment of patients with arterial hypertension].
    Kardiologiia, 2007, Volume: 47, Issue:11

    Topics: Adult; Calcium Channel Blockers; Diabetes Mellitus, Type 2; Dihydropyridines; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Humans; Hypercholesterolemia; Hypertension; Hypertrophy, Left Ventricular; Male; Middle Aged; Nifedipine; Obesity; Treatment Outcome; Verapamil

2007
Impact of an ACE inhibitor and calcium antagonist on microalbuminuria and lipid subfractions in type 2 diabetes: a randomised, multi-centre pilot study.
    Journal of human hypertension, 2002, Volume: 16, Issue:3

    Topics: Aged; Albuminuria; Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Apolipoproteins; Apoprotein(a); Benzazepines; Calcium Channel Blockers; Cholesterol; Cholesterol, HDL; Diabetes Mellitus, Type 2; Dihydropyridines; Female; Humans; Lipoprotein(a); Male; Middle Aged; Pilot Projects; Triglycerides

2002

Other Studies

1 other study(ies) available for 1,4-dihydropyridine and Diabetes Mellitus, Type 2

ArticleYear
Evidence-based triple antihypertensive therapy yields lower mortality in older patients with diabetes mellitus.
    Hypertension (Dallas, Tex. : 1979), 2014, Volume: 63, Issue:2

    Topics: Calcium Channel Blockers; Diabetes Mellitus, Type 2; Dihydropyridines; Drug Combinations; Female; Gliclazide; Humans; Hypertension; Indapamide; Male; Perindopril

2014